Capstan Therapeutics Stock

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

Sign up today and learn more about Capstan Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Capstan Therapeutics Stock

Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.

Funding History

November 2021$63.0M
September 2022$102M

Management

Director

Athena Countouriotis

Chief Technology Officer

Priya Karamali

Chief Financial Officer

Justin Thacker

General Counsel

Jeffrey Pepe

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo